Skip to main content
Log in

Imaging cardiac amyloidosis: Patient page

  • Theme Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Amyloidosis is a disease that develops when abnormally folded proteins collect together to form amyloid fibrils, which deposit in various organs and cause organ damage. Amyloidosis in the heart can be identified by using various imaging tests. This patient page provides an overview of imaging in cardiac amyloidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sharmila Dorbala MD, MPH, FASNC.

Ethics declarations

Disclosures

RHF has received consulting fees from Ionis Pharmaceuticals and Alnylam Pharmaceuticals and research funding from GlaxoSmithKline. SD has received consulting fees from Pfizer, GE Health Care, and AAA.

Additional information

Funding

SD and RF are supported by NIH RO1 Grant (RO1 HL 130563); SD is supported by American Heart Association Grant (AHA 16 CSA 2888 0004).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dorbala, S., Falk, R. Imaging cardiac amyloidosis: Patient page. J. Nucl. Cardiol. 26, 217–221 (2019). https://doi.org/10.1007/s12350-018-01551-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-018-01551-5

Keywords

Navigation